Strongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology Life Science Investing
Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting Life Science Investing
Intellipharmaceutics Announces Pricing of $5.2 Million Public Offering of Common Shares and Warrants Life Science Investing
PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences Biotech Investing
DelMar Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting with FDA on VAL-083 Life Science Investing
BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular Products Life Science Investing
OncBioMune Receives Patent on Paclitaxel-Gallium-Transferrin for Targeted Cancer Treatment Life Science Investing
Insys Therapeutics Successfully Completes Safety and Pharmacokinetic (PK) Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients Life Science Investing
PharmaCyte Biotech to Engage Principal Investigator for Clinical Trial in Pancreatic Cancer Biotech Investing
